What's new

EMEA-003185-PIP01-22

EMEA-003185-PIP01-22

May 20, 2025 - 16:15
 0
EMEA-003185-PIP01-22
EMEA-003185-PIP01-22
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Fasenra, Benralizumab...

Next Article

The D Brief: US strikes in Somalia; UAE seeks DOGE’d DOD workers; Trump-Putin ta...

Related Posts

EMA/FVE info session for veterinary practitioners : Understanding the first report of sales and use of antimicrobials in animals, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2024, 15:30 (CEST) to 3 June 2024, 16:30 (CEST)

EMA/FVE info session for veterinary practitioners : Und...

May 12, 2025  0

Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 15/05/2025 Positive

Summary of opinion: Bluevac BTV (previously Bluevac BTV...

May 16, 2025  0

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0